Impact of PD‐1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib‐Based Triple Therapy

Jian He, Jian Chen, Bohua Yu, Fuqun Wei, Weifu Liu, Peishu Huang, Songhui Wu, Xiang You, Zhisheng Chen, Ziqi Lin, Wuhua Guo, Shaowu Zhuang · 2026

Read Impact of PD‐1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib‐Based Triple Therapy by Jian He, Jian Chen, Bohua Yu, Fuqun Wei, Weifu Liu, Peishu Huang, Songhui Wu, Xiang You, Zhisheng Chen, Ziqi Lin, Wuhua Guo, Shaowu Zhuang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13522736.txt.

Description

Jian He leads a multicenter 2026 study asking whether the timing of immunotherapy matters in unresectable liver cancer treated with combined therapy. Three hundred fifty patients at six academic centers received local artery-based treatment plus the drug lenvatinib and a PD-1 inhibitor, a type of immune checkpoint drug. Patients were grouped by whether the immune drug started before or after the local treatment.

Starting the immune drug first was linked to longer overall survival in the full group, driven mainly by patients receiving arterial infusion chemotherapy rather than artery-blocking treatment. The benefit held after statistical matching and landmark checks, and response rates were higher with early immune treatment. Progression-free survival also improved in the infusion group. The authors suggest sequencing deserves attention when planning triple therapy.

Catalog record

CREATORJian He, Jian Chen, Bohua Yu, Fuqun Wei, Weifu Liu, Peishu Huang, Songhui Wu, Xiang You, Zhisheng Chen, Ziqi Lin, Wuhua Guo, Shaowu Zhuang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13522736

Browse the full library · About the Tower of Babel